GB9806312D0 - Novel formulations - Google Patents

Novel formulations

Info

Publication number
GB9806312D0
GB9806312D0 GBGB9806312.6A GB9806312A GB9806312D0 GB 9806312 D0 GB9806312 D0 GB 9806312D0 GB 9806312 A GB9806312 A GB 9806312A GB 9806312 D0 GB9806312 D0 GB 9806312D0
Authority
GB
United Kingdom
Prior art keywords
novel formulations
formulations
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9806312.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9806312.6A priority Critical patent/GB9806312D0/en
Publication of GB9806312D0 publication Critical patent/GB9806312D0/en
Priority to EA200000977A priority patent/EA003393B1/ru
Priority to BR9908991-2A priority patent/BR9908991A/pt
Priority to HU0101326A priority patent/HUP0101326A3/hu
Priority to AU30451/99A priority patent/AU754765B2/en
Priority to NZ506893A priority patent/NZ506893A/xx
Priority to IDW20001883A priority patent/ID26485A/id
Priority to CN99804347A priority patent/CN1125639C/zh
Priority to JP2000537547A priority patent/JP2002507569A/ja
Priority to IL13847899A priority patent/IL138478A0/xx
Priority to CA002324612A priority patent/CA2324612A1/en
Priority to SK1410-2000A priority patent/SK14102000A3/sk
Priority to EP99911940A priority patent/EP1063993A1/en
Priority to TR2000/02750T priority patent/TR200002750T2/xx
Priority to PL99343095A priority patent/PL343095A1/xx
Priority to APAP/P/2000/001914A priority patent/AP2000001914A0/en
Priority to PCT/GB1999/000922 priority patent/WO1999048499A1/en
Priority to NO20004740A priority patent/NO313404B1/no
Priority to ZA200005697A priority patent/ZA200005697B/xx
Priority to BG104865A priority patent/BG104865A/xx
Priority to US10/134,917 priority patent/US6699882B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB9806312.6A 1998-03-24 1998-03-24 Novel formulations Ceased GB9806312D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB9806312.6A GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations
PCT/GB1999/000922 WO1999048499A1 (en) 1998-03-24 1999-03-24 Paroxetine compositions
CA002324612A CA2324612A1 (en) 1998-03-24 1999-03-24 Paroxetine compositions
EP99911940A EP1063993A1 (en) 1998-03-24 1999-03-24 Paroxetine compositions
HU0101326A HUP0101326A3 (en) 1998-03-24 1999-03-24 Paroxetine compositions and process for their preparation
AU30451/99A AU754765B2 (en) 1998-03-24 1999-03-24 Paroxetine compositions
NZ506893A NZ506893A (en) 1998-03-24 1999-03-24 Paroxetine compositions adsorbed or absorbed by a solid carrier
IDW20001883A ID26485A (id) 1998-03-24 1999-03-24 Komposisi paroksetina
CN99804347A CN1125639C (zh) 1998-03-24 1999-03-24 帕罗西汀组合物
JP2000537547A JP2002507569A (ja) 1998-03-24 1999-03-24 パロキセチン組成物
IL13847899A IL138478A0 (en) 1998-03-24 1999-03-24 Paroxetine compositions
EA200000977A EA003393B1 (ru) 1998-03-24 1999-03-24 Композиции пароксетина
SK1410-2000A SK14102000A3 (sk) 1998-03-24 1999-03-24 Paroxetín alebo jeho farmaceuticky prijateľný derivát, farmaceutický prostriedok s jeho obsahom a jeho použitie
BR9908991-2A BR9908991A (pt) 1998-03-24 1999-03-24 Composições de paroxetina
TR2000/02750T TR200002750T2 (tr) 1998-03-24 1999-03-24 Paroksetin terkipler.
PL99343095A PL343095A1 (en) 1998-03-24 1999-03-24 Paroxetine compositions
APAP/P/2000/001914A AP2000001914A0 (en) 1998-03-24 1999-03-24 Paroxetine compositions.
NO20004740A NO313404B1 (no) 1998-03-24 2000-09-22 Farmasöytisk preparat omfattende paroksetin, fremgangsmåte for fremstilling av preparatet, samt anvendelse derav
ZA200005697A ZA200005697B (en) 1998-03-24 2000-10-16 Paroxetine compositions.
BG104865A BG104865A (en) 1998-03-24 2000-10-16 Paroxetinne-containing compositions
US10/134,917 US6699882B2 (en) 1998-03-24 2002-04-29 Paroxetine compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9806312.6A GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations

Publications (1)

Publication Number Publication Date
GB9806312D0 true GB9806312D0 (en) 1998-05-20

Family

ID=10829181

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9806312.6A Ceased GB9806312D0 (en) 1998-03-24 1998-03-24 Novel formulations

Country Status (20)

Country Link
EP (1) EP1063993A1 (ja)
JP (1) JP2002507569A (ja)
CN (1) CN1125639C (ja)
AP (1) AP2000001914A0 (ja)
AU (1) AU754765B2 (ja)
BG (1) BG104865A (ja)
BR (1) BR9908991A (ja)
CA (1) CA2324612A1 (ja)
EA (1) EA003393B1 (ja)
GB (1) GB9806312D0 (ja)
HU (1) HUP0101326A3 (ja)
ID (1) ID26485A (ja)
IL (1) IL138478A0 (ja)
NO (1) NO313404B1 (ja)
NZ (1) NZ506893A (ja)
PL (1) PL343095A1 (ja)
SK (1) SK14102000A3 (ja)
TR (1) TR200002750T2 (ja)
WO (1) WO1999048499A1 (ja)
ZA (1) ZA200005697B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914600D0 (en) * 1999-06-22 1999-08-25 Smithkline Beecham Plc Novel,process
DK200100341A (da) * 2001-03-02 2002-09-03 Gea Farmaceutisk Fabrik As Fremgangsmåde til fremstilling af farmaceutiske tabletter indeholdende paroxetinhydrochlorid-anhydrat
MXPA06000111A (es) * 2003-07-02 2006-04-27 Abbott Lab Proceso para preparar formulaciones de farmacos que regulan lipidos.
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
HU1000278D0 (en) * 2010-05-28 2010-07-28 Egis Gyogyszergyar Nyilvanosan Novel pharmaceutical use uf silicic acid
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法
CN104027306A (zh) * 2014-06-25 2014-09-10 万特制药(海南)有限公司 帕罗西汀口服混悬液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
SK283608B6 (sk) * 1995-02-06 2003-10-07 Smithkline Beecham Plc Bezvodý hydrochlorid paroxetínu, spôsob jeho výroby a použitie
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride

Also Published As

Publication number Publication date
TR200002750T2 (tr) 2000-12-21
IL138478A0 (en) 2001-10-31
ID26485A (id) 2001-01-11
EA003393B1 (ru) 2003-04-24
CA2324612A1 (en) 1999-09-30
EA200000977A1 (ru) 2001-02-26
AU3045199A (en) 1999-10-18
HUP0101326A3 (en) 2002-06-28
BR9908991A (pt) 2000-12-12
WO1999048499A1 (en) 1999-09-30
NO20004740D0 (no) 2000-09-22
PL343095A1 (en) 2001-07-30
AP2000001914A0 (en) 2000-09-30
AU754765B2 (en) 2002-11-21
NO20004740L (no) 2000-10-03
EP1063993A1 (en) 2001-01-03
NO313404B1 (no) 2002-09-30
NZ506893A (en) 2003-06-30
CN1294512A (zh) 2001-05-09
JP2002507569A (ja) 2002-03-12
HUP0101326A2 (hu) 2002-05-29
BG104865A (en) 2001-05-31
SK14102000A3 (sk) 2001-03-12
CN1125639C (zh) 2003-10-29
ZA200005697B (en) 2001-10-02

Similar Documents

Publication Publication Date Title
GB9804013D0 (en) Formulations
GB9715751D0 (en) Formulations
AP2000001874A0 (en) Cellecoxib compositions
IL139541A0 (en) Novel particulate formulations
PL341642A1 (en) Novel macrolydes
GB9811377D0 (en) Compositions
EP1068213A4 (en) SILOXANES WITH AMINO-ORGANIC FUNCTIONAL GROUP
IL139733A0 (en) Novel compositions
GB9806312D0 (en) Novel formulations
GB2339693B (en) Anti-mollusc compositions
GB9805782D0 (en) Compositions
GB9810180D0 (en) Novel formulation
GB9806810D0 (en) Compositions
GB0016470D0 (en) Compositions
GB9815002D0 (en) Formulations
GB9815001D0 (en) Formulations
GB2336535B (en) Compositions
GB9809347D0 (en) Compositions
GB9810181D0 (en) Novel formulations
GB9605948D0 (en) Novel formulations
GB9818910D0 (en) Novel formulation
GB9818905D0 (en) Novel formulation
GB9703101D0 (en) Formulations
GB9704521D0 (en) Formulations
GB9703099D0 (en) Formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)